Department of Biotechnology and Life Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology, Tokyo 184-8588, Japan.
Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Graduate School of Medical and Dental Science, Kagoshima University, Kagoshima 890-8544, Japan.
Anal Chem. 2023 Oct 3;95(39):14675-14685. doi: 10.1021/acs.analchem.3c02560. Epub 2023 Sep 7.
This paper describes a strategy for simultaneous recognition of over- and under-expressed microRNAs (miRNAs) using the method of signal classification-based nanopore decoding. MiRNA has attracted attention as a promising biomarker for cancer diagnosis owing to its cancer-type-specific expression patterns. While nanopore technology has emerged as a simple and label-free method to detect miRNAs and their expression patterns, recognizing patterns involving simultaneous over/under-expression is still challenging due to the inherent working principles. Here, inspired by the sequence design for DNA computation with nanopore decoding, we designed diagnostic DNA probes targeting two individual over/under-expressed miRNAs in the serum of oral squamous cell carcinoma. Through nanopore measurements, our designed probes exhibited characteristic current signals depending on the hybridized miRNA species, which were plotted on the scatter plot of duration versus current blocking ratio. The classified signals reflected the relative abundance of target miRNAs, thereby enabling successful pattern recognition of over/under-expressed miRNAs, even when using clinical samples. We believe that our method paves the way for miRNA-targeting simple diagnosis as a liquid biopsy.
本文提出了一种利用信号分类纳米孔解码方法同时识别过表达和低表达 microRNA(miRNA)的策略。miRNA 因其具有肿瘤特异性表达模式而作为癌症诊断的有前途的生物标志物引起了关注。尽管纳米孔技术已成为一种简单且无需标记的检测 miRNA 及其表达模式的方法,但由于其固有工作原理,识别涉及同时过表达/低表达的模式仍然具有挑战性。在这里,受纳米孔解码 DNA 计算序列设计的启发,我们设计了针对口腔鳞状细胞癌血清中两种单独过表达/低表达 miRNA 的诊断 DNA 探针。通过纳米孔测量,我们设计的探针表现出取决于杂交 miRNA 种类的特征电流信号,这些信号绘制在持续时间与电流阻断比的散点图上。分类信号反映了靶 miRNA 的相对丰度,从而能够成功识别过表达/低表达 miRNA 的模式,即使使用临床样本也是如此。我们相信,我们的方法为 miRNA 靶向的简单诊断开辟了道路,作为一种液体活检。